Search Results

Toxic disruptions: polycystic ovary syndrome in urban India: by Gauri Pathak, London and New York, Routledge, 2023, 158pp, GBP 120 (hardback), ISBN 9781032669274.

• Authors : Majumdar, Anindita¹ (AUTHOR)

Subjects: *INDIAN women (Asians); *SEXUAL cycle; *ENDOCRINE diseases

• Source: New Genetics & Society. Dec2024, Vol. 43 Issue 1, p1-3. 3p.

Record details

A Substantive Resource for Diverse Medical Conditions Affecting Cognition.

Subjects: *COGNITION; *ENDOCRINE diseases; *DRUGS

• Source: Archives of Clinical Neuropsychology. Sep2020, Vol. 35 Issue 6, p765-767. 3p.

Record details

TOPICAL STEROID POTENCIES.

Subjects: *STEROIDS; *ENDOCRINE diseases; *THERAPEUTICSROXANE Laboratories Inc. ROXANE Laboratories Inc. ROXANE Laboratories Inc. 058839929 ; GALDERMA Laboratories LP ; PFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE

• Source: Monthly Prescribing Reference. Sep2014, Vol. 30 Issue 9, p61-64. 4p.

Record details

Chapter 4: ENDOCRINE DISORDERS: 4A: Corticosteroid-responsive disorders.

Subjects: *ENDOCRINE diseases; *THERAPEUTICS; THERAPEUTIC use of glucocorticoidsPFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE; CONCORDIA (Company) ; HORIZON Pharma PLC

• Source: Monthly Prescribing Reference. Aug2014, Vol. 30 Issue 8, p65-67. 3p.

Record details

ENDOCRINE DISORDERS.

Subjects: *ENDOCRINE diseases; *GLUCOCORTICOIDS; *THERAPEUTICSPFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE; CONCORDIA Pharmaceuticals (Company) ; UCB Inc.

• Source: MPR - Pediatricians' Edition. Spring/Summer2015, Vol. 26 Issue 1, p28-34. 7p.

Record details

ENDOCRINE DISORDERS.

Subjects: *ENDOCRINE diseases; *THERAPEUTICSPFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE; CONCORDIA Pharmaceuticals (Company) ; UCB Chemical Corp.

• Source: MPR - Pediatricians' Edition. Fall/Winter2014/2015, Vol. 25 Issue 2, p29-34. 6p.

Record details

ENDOCRINE DISORDERS.

Subjects: *PHARMACEUTICAL industry; *ENDOCRINE diseases; *DRUGSPFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE; SHIONOGI Pharma Inc. ; SANOFI-Aventis SA

• Source: MPR - Pediatricians' Edition. Spring/Summer2013, Vol. 24 Issue 1, p30-36. 7p.

Record details

ENDOCRINE DISORDERS.

Subjects: *ENDOCRINE diseases; *GLUCOCORTICOIDS; *ANTI-inflammatory agentsPFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE; SHIONOGI & Co. Ltd. ; UCB SA UCB SA UCB SA 043546522

• Source: MPR - Pediatricians' Edition. Fall/Winter2012, Vol. 23 Issue 2, p30-36. 7p. 2 Charts.

Record details

ENDOCRINE DISORDERS.

Subjects: *DRUGS; *ENDOCRINE diseases; *THERAPEUTICSPFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE; CONCORDIA (Company) ; SANOFI-Aventis SA

• Source: MPR - Pharmacists' Edition. Spring2016, Vol. 10 Issue 1, p56-77. 22p.

Record details

ENDOCRINE DISORDERS.

Subjects: *ENDOCRINE diseases; *PREDNISOLONE; *HYDROCORTISONESHIONOGI & Co. Ltd. ; HORIZON Pharma PLC ; PFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE

• Source: MPR - Pharmacists' Edition. Summer2013, Vol. 7 Issue 2, p65-86. 22p. 4 Charts.

Record details